Skip to main content
. 2021 Apr 23;12:665416. doi: 10.3389/fgene.2021.665416

Figure 4.

Figure 4

Kaplan–Meier (K–M) survival analysis for patients which are classified using different methods. (A) KM survival curve for labeled samples, whose subtypes are known in advance. (B) KM survival analysis for unlabeled samples, which are classified using complex biological processes–joint matrix tri-factorization (CBP-JMF) on mRNA expression and miRNA expression data. (C) KM survival analysis for unlabeled patients, which are classified using CBP-JMF only on mRNA expression. (D) KM survival analysis for unlabeled patients, which are classified on mRNA expression and miRNA expression data without graph embedding regularization.